ArticleGlobal epidemiology2025
Epidemiology of multimorbidity among indigenous adults: Insights from a large-scale population survey of 53 different indigenous groups in East India.
Article in Global epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Asthma and Multimorbidity Amongst Ethnic Minority Groups in High Income Countries.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026Review
- Multimorbidity among indigenous tribal communities in Kerala, India: a cross-sectional study (2022-2024).The Lancet regional health. Southeast Asia · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Indigenous populations in India face a growing burden of multimorbidity, yet data on its prevalence and patterns remain scarce. This study estimated the prevalence, determinants, and co-occurrence of multimorbidity among Indigenous adults using data from the Odisha Tribal Family Health Survey (OTFHS). Methods: The analysis included 19,430 adults (≥18 years) from 9711 households across 14 districts, representing 53 Indigenous groups, including 13 Particularly Vulnerable Tribal Groups (PVTGs). Multimorbidity-defined as having ≥2 chronic conditions-was assessed through self-reports and laboratory results. Prevalence estimates used descriptive statistics; associated factors were identified via ordinal logistic regression, and co-occurrence patterns of chronic conditions were visualized using a matrix-based plot that displays the frequency and overlap of conditions (UpSet plot). Results: The weighted prevalence of multimorbidity was 21.7 % (95 % CI: 20.5 %, 22.9 %), increasing from 3.8 % in those aged 18-25 to 48.2 % in those 60 and older. Regression analysis showed that older age, male sex, and tobacco and alcohol use were significantly associated with higher odds of multimorbidity. Hypertension was the most prevalent condition, often co-occurring with kidney disease, liver disease, or back pain. Conclusion: These findings highlight the urgent need for age- and sex-sensitive, integrated health interventions tailored to Indigenous communities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.